What is ICR's earnings per share (EPS)?

ICR (ICR) reported diluted earnings per share of $-0.75 for fiscal year 2025. This represents a -213.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ICR Financials

ICR

Source SEC Filings (10-K/10-Q) Updated May 8, 2026 Currency USD FYE December

This page shows ICR (ICR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of ICR's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

ICR's revenue declined 5.7% year-over-year, from $24.4M to $23.0M. This contraction results in a growth score of 0/100.

Leverage

ICR carries a low D/E ratio of 1.34, meaning only $1.34 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.

Returns

ICR generates a -0.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 13/100. This is down from 5.2% the prior year.

Piotroski F-Score Weak

3/9

ICR passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-7.24x

For every $1 of reported earnings, ICR generates $-7.24 in operating cash flow ($11.4M OCF vs -$1.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$23.0M

YoY-5.7%

5Y CAGR-1.0%

ICR generated $23.0M in revenue in fiscal year 2025. This represents a decrease of 5.7% from the prior year.

EBITDA

N/A

Net Income

-$1.6M

YoY-112.4%

ICR reported -$1.6M in net income in fiscal year 2025. This represents a decrease of 112.4% from the prior year.

EPS (Diluted)

$-0.75

YoY-213.6%

ICR earned $-0.75 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 213.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$76.6M

YoY+18.6%

5Y CAGR+1.2%

ICR held $76.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-6.8%

YoY-58.8pp

5Y CAGR+112.4pp

ICR's net profit margin was -6.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 58.8 percentage points from the prior year.

Return on Equity

-0.7%

YoY-5.9pp

5Y CAGR+11.3pp

ICR's ROE was -0.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ICR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$23.0M-5.7%	$24.4M-37.1%	$38.8M+1.9%	$38.0M+34.5%	$28.3M+17.2%	$24.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$24.0M-34.4%	$36.5M-13.5%	$42.2M+97.4%	$21.4M+142.8%	$8.8M-14.7%	$10.3M
Income Tax	$0	$0-100.0%	$22K	$0	$0	N/A
Net Income	-$1.6M-112.4%	$12.7M+385.5%	-$4.4M-143.6%	$10.2M+3.1%	$9.9M+134.3%	-$28.8M
EPS (Diluted)	$-0.75-213.6%	$0.66+164.1%	$-1.03-345.2%	$0.42-41.7%	$0.72+128.9%	$-2.49

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$5.2M-14.7%	$6.1M+15.9%	$5.2M-11.8%	$5.9M+2.4%	$5.8M-12.0%	$6.6M+0.4%	$6.5M+16.4%	$5.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$4.5M-11.2%	$5.1M-8.9%	$5.6M-12.5%	$6.4M-5.6%	$6.8M-16.9%	$8.2M-13.7%	$9.5M+1.4%	$9.4M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0
Net Income	-$4.1M-334.3%	-$954K+87.5%	-$7.6M-348.6%	$3.1M-22.2%	$3.9M+7.7%	$3.7M+495.9%	$615K-87.7%	$5.0M
EPS (Diluted)	$-0.56	N/A	$-0.90-662.5%	$0.16-33.3%	$0.24	N/A	$-0.09-125.7%	$0.35

ICR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$529.2M-20.0%	$661.3M-15.3%	$780.3M-14.7%	$914.5M+19.6%	$764.4M+37.7%	$555.0M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$76.6M+18.6%	$64.5M+19.2%	$54.1M+84.1%	$29.4M-48.6%	$57.3M-20.6%	$72.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$303.0M-27.3%	$416.7M-21.3%	$529.8M-16.7%	$635.9M+39.1%	$457.3M+45.3%	$314.7M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$226.2M-7.5%	$244.6M-2.4%	$250.6M-10.1%	$278.6M-9.3%	$307.1M+27.8%	$240.3M
Retained Earnings	-$115.1M-21.2%	-$95.0M-6.6%	-$89.0M-46.1%	-$60.9M-16.6%	-$52.3M-10.6%	-$47.3M

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$513.4M-3.0%	$529.2M-4.3%	$552.8M-10.3%	$616.4M-6.2%	$657.2M-0.6%	$661.3M-9.1%	$727.9M-0.9%	$734.2M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$80.0M+4.5%	$76.6M+8.0%	$70.9M+162.3%	$27.0M-54.3%	$59.1M-8.4%	$64.5M+9.7%	$58.8M+32.0%	$44.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$295.9M-2.3%	$303.0M-5.8%	$321.7M-13.8%	$373.0M-9.7%	$413.3M-0.8%	$416.7M-13.6%	$482.3M-0.5%	$484.6M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$217.5M-3.9%	$226.2M-2.1%	$231.1M-5.0%	$243.3M-0.2%	$243.9M-0.3%	$244.6M-0.4%	$245.6M-1.6%	$249.6M
Retained Earnings	-$123.9M-7.6%	-$115.1M-5.1%	-$109.5M-12.6%	-$97.2M-1.6%	-$95.7M-0.7%	-$95.0M-1.0%	-$94.0M-4.5%	-$89.9M

ICR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$11.4M-36.6%	$18.0M+11.0%	$16.2M-12.5%	$18.5M+59.0%	$11.6M-3.0%	$12.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$136.3M+6.9%	$127.6M+32.2%	$96.5M+153.5%	-$180.6M+18.8%	-$222.4M-235.7%	$163.9M
Financing Cash Flow	-$133.2M+1.5%	-$135.2M-53.6%	-$88.0M-165.6%	$134.2M-31.5%	$195.9M+238.5%	-$141.5M
Dividends Paid	$12.6M0.0%	$12.6M+0.7%	$12.5M+0.5%	$12.4M+0.5%	$12.4M+33.9%	$9.3M
Share Buybacks	N/A	$0	$0-100.0%	$22.4M+56.0%	$14.3M+1778.8%	$763K

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$2.0M-19.7%	$2.5M-14.1%	$2.9M-11.8%	$3.2M+14.7%	$2.8M-38.2%	$4.6M-16.6%	$5.5M+46.2%	$3.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$13.8M-45.0%	$25.1M-75.0%	$100.6M+782.5%	$11.4M+1675.9%	-$723K-101.0%	$71.8M+307.2%	$17.6M+87.3%	$9.4M
Financing Cash Flow	-$12.3M+45.1%	-$22.3M+60.5%	-$56.6M-21.1%	-$46.7M-520.6%	-$7.5M+89.3%	-$70.6M-698.2%	-$8.8M+69.5%	-$29.0M
Dividends Paid	$3.2M0.0%	$3.2M0.0%	$3.2M+0.1%	$3.1M-0.1%	$3.2M0.0%	$3.2M0.0%	$3.2M0.0%	$3.1M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ICR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-6.8%-58.8pp	51.9%+63.4pp	-11.4%-38.2pp	26.8%-8.1pp	34.9%+154.1pp	-119.2%
Return on Equity	-0.7%-5.9pp	5.2%+7.0pp	-1.8%-5.4pp	3.6%+0.4pp	3.2%+15.2pp	-12.0%
Return on Assets	-0.3%-2.2pp	1.9%+2.5pp	-0.6%-1.7pp	1.1%-0.2pp	1.3%+6.5pp	-5.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.34-0.4	1.70-0.4	2.11-0.2	2.28+0.8	1.49+0.2	1.31
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-80.1%-64.4pp	-15.7%+130.4pp	-146.1%-198.0pp	51.8%-16.4pp	68.2%+12.5pp	55.7%+46.3pp	9.4%-79.3pp	88.7%
Return on Equity	-1.9%-1.5pp	-0.4%+2.9pp	-3.3%-4.6pp	1.3%-0.4pp	1.6%+0.1pp	1.5%+1.3pp	0.3%-1.8pp	2.0%
Return on Assets	-0.8%-0.6pp	-0.2%+1.2pp	-1.4%-1.9pp	0.5%-0.1pp	0.6%+0.1pp	0.5%+0.5pp	0.1%-0.6pp	0.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.36+0.0	1.34-0.1	1.39-0.1	1.53-0.2	1.690.0	1.70-0.3	1.96+0.0	1.94
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is ICR's annual revenue?

ICR (ICR) reported $23.0M in total revenue for fiscal year 2025. This represents a -5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ICR's revenue growing?

ICR (ICR) revenue declined by 5.7% year-over-year, from $24.4M to $23.0M in fiscal year 2025.

Is ICR profitable?

No, ICR (ICR) reported a net income of -$1.6M in fiscal year 2025, with a net profit margin of -6.8%.

What is ICR's net profit margin?

ICR (ICR) had a net profit margin of -6.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ICR's return on equity (ROE)?

ICR (ICR) has a return on equity of -0.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ICR's operating cash flow?

ICR (ICR) generated $11.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ICR's total assets?

ICR (ICR) had $529.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What is ICR's debt-to-equity ratio?

ICR (ICR) had a debt-to-equity ratio of 1.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ICR's return on assets (ROA)?

ICR (ICR) had a return on assets of -0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ICR's Piotroski F-Score?

ICR (ICR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ICR's earnings high quality?

ICR (ICR) has an earnings quality ratio of -7.24x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ICR?

ICR (ICR) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.